Log in to save to my catalogue

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Canc...

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10507489

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

About this item

Full title

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

Publisher

Chicago: American Medical Association

Journal title

JAMA network open, 2023-09, Vol.6 (9), p.e2334208-e2334208

Language

English

Formats

Publication information

Publisher

Chicago: American Medical Association

More information

Scope and Contents

Contents

Importance Black men have higher incidence and mortality from prostate cancer. Whether precision oncology disparities affect Black men with metastatic castration-resistant prostate cancer (mCRPC) is unknown. Objective To compare precision medicine data and outcomes between Black and White men with mCRPC. Design, Setting, and Participants This retro...

Alternative Titles

Full title

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10507489

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10507489

Other Identifiers

ISSN

2574-3805

E-ISSN

2574-3805

DOI

10.1001/jamanetworkopen.2023.34208

How to access this item